ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Serological and molecular evaluation of Senecavirus A (SVA) in pigs from farrow-to-finish farms in Minas Gerais, Brazil.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- IRES Mutation Confers a Replicative Advantage to SVA by Enhancing Translation Efficiency.Transboundary and emerging diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of Senecavirus A (SVA) as a causative agent of vesicular diseases in pigs is noteworthy, since it was identified in 2014 through outbreaks in Brazil. The SVA belongs to the Picornaviridae family and is a non-enveloped virus with the ability to adapt to the environment. As the virus's stability allows it to persist on farms post-outbreak, maintaining stringent biosecurity measures is crucial for effective control. This study aims to evaluate antibody response and viral RNA shedding in swine farms. Blood and fecal samples were collected from pigs in 2022 on farms that experienced outbreaks in 2015 and 2016. The sampled pigs were from farrow-to-finish farms without clinical signs of SVA obtained from five farms in Minas Gerais state, Brazil, covering all production phases: sows, farrowing, nursery piglets, growing, and finishing pigs. Real-time PCR and serum neutralization tests were conducted. Antibodies against SVA were detected in all production phases from four of the positive farms, with sows showing the highest antibody prevalence. Viral RNA was found in fecal samples from two farms, with the farrowing phase pigs exhibiting the highest viral RNA positivity. These findings indicate the presence of SVA infection on farms with no clinical signs, suggesting that the virus may have persisted following previous outbreaks due to its environmental stability. This study provides a comprehensive profile of antibody and viral RNA presence across different production phases, which may be applicable for informing biosafety measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.